As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs ...

Eli Lilly (LLY) rally comes under scrutiny as Novo Nordisk (NVO) readies key late-stage trial results for its GLP-1 pill ...

A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss ...

Novo Nordisk was the leader in the space until Eli Lilly launched tirzepatide. The Denmark-based pharmaceutical giant markets ...

Shares of Lilly rose as much as 1.7% on Friday, pushing its market value to about $1 trillion, according to data compiled by ...

Eli Lilly, the drugmaker company’s valuation has soared to $1 trillion as the demand grows due to the weight-loss boom. This ...

Bengaluru: Eli Lilly just hit a USD 1 trillion in market value, becoming the first-ever pharmaceutical company to join the ...

US pharma giant Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1 trillion market valuation, a sharp turnaround from this summer when its stock was hit by disappointing ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

Eli Lilly surpassed a $1 trillion market capitalization this week. Why? Expectations-beating growth from Mounjaro and ...

Several of the environmental advocates and vaccine skeptics who helped propel Kennedy into politics have become impatient ...